These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 38263092)
1. Decrypting orphan GPCR drug discovery via multitask learning. Huang WC; Lin WT; Hung MS; Lee JC; Tung CW J Cheminform; 2024 Jan; 16(1):10. PubMed ID: 38263092 [TBL] [Abstract][Full Text] [Related]
2. Orphan receptor ligand discovery by pickpocketing pharmacological neighbors. Ngo T; Ilatovskiy AV; Stewart AG; Coleman JL; McRobb FM; Riek RP; Graham RM; Abagyan R; Kufareva I; Smith NJ Nat Chem Biol; 2017 Feb; 13(2):235-242. PubMed ID: 27992882 [TBL] [Abstract][Full Text] [Related]
3. Advancements in therapeutically targeting orphan GPCRs. Stockert JA; Devi LA Front Pharmacol; 2015; 6():100. PubMed ID: 26005419 [TBL] [Abstract][Full Text] [Related]
4. WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest. Wu J; Zhang Q; Wu W; Pang T; Hu H; Chan WKB; Ke X; Zhang Y Bioinformatics; 2018 Jul; 34(13):2271-2282. PubMed ID: 29432522 [TBL] [Abstract][Full Text] [Related]
5. Homologous G Protein-Coupled Receptors Boost the Modeling and Interpretation of Bioactivities of Ligand Molecules. Wu J; Sun Y; Chan WKB; Zhu Y; Zhu W; Huang W; Hu H; Yan S; Pang T; Ke X; Li F J Chem Inf Model; 2020 Mar; 60(3):1865-1875. PubMed ID: 32040913 [TBL] [Abstract][Full Text] [Related]
6. Precise modelling and interpretation of bioactivities of ligands targeting G protein-coupled receptors. Wu J; Liu B; Chan WKB; Wu W; Pang T; Hu H; Yan S; Ke X; Zhang Y Bioinformatics; 2019 Jul; 35(14):i324-i332. PubMed ID: 31510691 [TBL] [Abstract][Full Text] [Related]
7. Computational Prediction of Compound-Protein Interactions for Orphan Targets Using CGBVS. Kanai C; Kawasaki E; Murakami R; Morita Y; Yoshimori A Molecules; 2021 Aug; 26(17):. PubMed ID: 34500569 [TBL] [Abstract][Full Text] [Related]
8. Multi-source transfer learning with Graph Neural Network for excellent modelling the bioactivities of ligands targeting orphan G protein-coupled receptors. Huang S; Zheng S; Chen R Math Biosci Eng; 2023 Jan; 20(2):2588-2608. PubMed ID: 36899548 [TBL] [Abstract][Full Text] [Related]
9. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314 [TBL] [Abstract][Full Text] [Related]
10. Orphan G protein-coupled receptors: the ongoing search for a home. Jobe A; Vijayan R Front Pharmacol; 2024; 15():1349097. PubMed ID: 38495099 [TBL] [Abstract][Full Text] [Related]
11. Using silico methods predicting ligands for orphan GPCRs. Jiang Z; Zhou Y Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696 [TBL] [Abstract][Full Text] [Related]
12. Virtual screening of GPCRs: an in silico chemogenomics approach. Jacob L; Hoffmann B; Stoven V; Vert JP BMC Bioinformatics; 2008 Sep; 9():363. PubMed ID: 18775075 [TBL] [Abstract][Full Text] [Related]
13. Transfer learning with molecular graph convolutional networks for accurate modeling and representation of bioactivities of ligands targeting GPCRs without sufficient data. Wu J; Lan C; Mei Z; Chen X; Zhu Y; Hu H; Diao Y Comput Biol Chem; 2022 Jun; 98():107664. PubMed ID: 35325760 [TBL] [Abstract][Full Text] [Related]
15. 7TM Domain Structure of Adhesion GPCRs. de Graaf C; Nijmeijer S; Wolf S; Ernst OP Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483 [TBL] [Abstract][Full Text] [Related]
16. In vitro profiling of orphan G protein coupled receptor (GPCR) constitutive activity. Watkins LR; Orlandi C Br J Pharmacol; 2021 Aug; 178(15):2963-2975. PubMed ID: 33784795 [TBL] [Abstract][Full Text] [Related]
17. Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design. Basith S; Cui M; Macalino SJY; Park J; Clavio NAB; Kang S; Choi S Front Pharmacol; 2018; 9():128. PubMed ID: 29593527 [TBL] [Abstract][Full Text] [Related]
18. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches. Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212 [TBL] [Abstract][Full Text] [Related]
19. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You? Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092 [TBL] [Abstract][Full Text] [Related]
20. Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals. Tang H; Shu C; Chen H; Zhang X; Zang Z; Deng C PLoS Biol; 2019 Mar; 17(3):e3000175. PubMed ID: 30840614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]